We came across a bullish thesis on Bruker Corporation on r/valueinvesting by TheDynamicMolecule. In this article, we will ...
The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...
CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research ...
The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization ...
We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. 10x Genomics, Inc. is one of the seven stocks on our list of most promising stocks. On December 15, 2025, ...
Hosted on MSN
Citigroup downgrades 10x Genomics (TXG)
Fintel reports that on December 11, 2025, Citigroup downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from Buy to Neutral. Analyst Price Forecast Suggests 1.96% Upside As of December 6, 2025, ...
Spatial ribonucleic acid (RNA) transcriptomics measures gene expression while preserving each molecule’s coordinates in intact tissue, tying transcripts to histology and local microenvironments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback